Article
KIT mutations in a series of melanomas and their impact on treatment with imatinib.
Actas dermo-sifiliograficas - 1 Nov 2012
Botella-Estrada R, Soriano V, Rubio L, Nagore E
Abstract excerpt
No abstract is available from the source.
Topics
- Antineoplastic Agents
- Benzamides
- Humans
- Imatinib Mesylate
- Male
- Melanoma
- Middle Aged
- Mutation
- Piperazines
- Pyrimidines
- Skin Neoplasms
- Treatment Outcome
